Revolution Medicines, Inc. (RVMDW) stock

RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 3/30

$9.81+0.18 (+1.82%)

Close on Oct 30, 2026Market cap $41.00BP/E –Yield –

Revolution Medicines gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Revolution Medicines's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RVMDW.

Advertisement
300 × 250